• Apoptotic Priming in Glioblastoma: Targeting BCL-XL and MCL-

  2026-07-25

  This article analyzes a recent study revealing that glioblastoma cells, especially stem-like subpopulations, display heightened apoptotic priming due to elevated expression of anti-apoptotic BCL-XL and MCL-1. The findings highlight the therapeutic potential of sequential BCL-XL and MCL-1 inhibition with BH3-mimetics for overcoming treatment resistance in glioblastoma.

• Leupeptin Hemisulfate Salt: Workflow Precision in Protease R

  2026-07-24

  Leupeptin hemisulfate salt empowers researchers with high-specificity, reversible inhibition of key serine and cysteine proteases, crucial for precise control in protein degradation and viral replication assays. This guide details experimental workflows, advanced applications, and troubleshooting strategies to maximize reliability in protease activity regulation studies.

• Sumatriptan’s Emerging Anti-Inflammatory Role: Systematic Re

  2026-07-24

  Ala et al. systematically reviewed evidence that sumatriptan, beyond its established use in migraine, exhibits reproducible anti-inflammatory effects across diverse experimental models. Their findings suggest sumatriptan modulates inflammatory mediators and signaling pathways, with potential implications for translational therapeutics outside neurology.

• Moxifloxacin in Research: Protocols and Advanced Use-Cases

  2026-07-23

  Moxifloxacin, a potent fluoroquinolone antibiotic, is revolutionizing cellular and metabolic research with reproducible, dose-dependent effects. This guide details experimental workflows, troubleshooting, and the unique advantages of APExBIO's Moxifloxacin for antibiotic toxicity and metabolic pathway studies.

• L-Threonine (SKU C6127): Reliable Optimization for Cell Assa

  2026-07-23

  This authoritative review addresses core laboratory challenges in cell viability and metabolic profiling, demonstrating how L-Threonine (SKU C6127) from APExBIO ensures reproducible, sensitive results across workflows. Integrating scenario-based Q&As, the article delivers practical strategies and evidence-driven solutions for biomedical researchers and technicians seeking validated amino acid supplementation.

• NF-κB/miR-202-5p/HMGB2 Feedback in Septic AKI Attenuation

  2026-07-22

  This study uncovers a negative feedback loop involving NF-κB, miR-202-5p, and HMGB2 that mitigates inflammation and cell death in sepsis-induced acute kidney injury (AKI). By elucidating how NF-κB-driven miR-202-5p induction targets HMGB2 and suppresses pathological inflammation, the research provides new mechanistic insight and therapeutic avenues for septic AKI.

• Metformin Hydrochloride in Fibrosis and Metabolic Research W

  2026-07-22

  Metformin Hydrochloride (Metformin HCl) offers unique advantages for dissecting fibrosis and metabolic signaling, especially through AMPK pathway modulation. This article translates recent breakthroughs—such as the attenuation of vocal fold fibrosis—into robust, reproducible protocols, troubleshooting guidance, and comparative insights for advanced metabolic research.

• Gamma-Linolenic Acid: Translational Leverage in Inflammation

  2026-07-21

  This thought-leadership article dissects the mechanistic and translational edge of gamma-linolenic acid (GLA) in anti-inflammatory research. It bridges molecular mechanisms with experimental strategy and clinical relevance, offering concrete guidance to translational researchers seeking robust, reproducible, and clinically-aligned approaches. By critically referencing recent antibacterial stewardship findings and integrating workflow recommendations, the article positions GLA, as supplied by APExBIO, at the forefront of next-generation inflammation research.

• LY2228820: Selective p38 MAP Kinase Inhibitor for Inflammati

  2026-07-21

  LY2228820 is a highly selective, ATP-competitive p38 MAP kinase inhibitor with nanomolar potency for p38α and p38β. It modulates key inflammatory signaling pathways and enhances the efficacy of other cytotoxic agents in cancer models. Its robust solubility and stability make it suitable for advanced anti-inflammatory and cancer research applications.

• Bovine Insulin: Optimizing Cell Culture Growth and Metabolis

  2026-07-20

  Bovine insulin, sourced from APExBIO, is a high-purity peptide hormone that excels as a growth factor supplement for cultured cells, boosting proliferation and metabolic fidelity. This article goes beyond conventional protocols, offering actionable, scenario-based guidance for maximizing reproducibility and troubleshooting common challenges in experimental cell culture workflows.

• Malate as a Translational Lever: Mechanistic and Strategic A

  2026-07-20

  This thought-leadership article examines the emerging role of malate ((S)-2-hydroxysuccinic acid) as a metabolic modulator within the context of translational research, particularly at the intersection of immune evasion and metabolic reprogramming in cancer. Through mechanistic insight, recent omics findings, and practical protocol guidance, we demonstrate how APExBIO's malate product enables researchers to dissect metabolic flux and immune-metabolic crosstalk, advancing both fundamental and applied discovery.

• WEHI-539: Precision BCL-XL Inhibitor for Apoptosis Workflows

  2026-07-19

  WEHI-539 delivers unmatched selectivity for BCL-XL inhibition, enabling researchers to dissect apoptotic resistance and sensitize cancer stem cells in chemoresistant models. This article provides actionable protocols, advanced troubleshooting, and a cross-study synthesis to maximize the impact of WEHI-539 in apoptosis research.

• Midecamycin: Protocols and Performance in Antibacterial Rese

  2026-07-18

  Midecamycin offers precision and versatility for microbiology researchers seeking robust inhibition of Gram-positive bacteria and advanced protein synthesis studies. This guide decodes experimental workflows, troubleshooting, and comparative strategies to maximize results with this acetoxy-substituted macrolide antibiotic.

• Ginsenoside Rg1 Restores Neuroimmune Balance Post-Anesthesia

  2026-07-17

  This study demonstrates that Ginsenoside Rg1, a triterpene saponin from Panax ginseng, reverses neuroimmune and behavioral disruptions resulting from prolonged isoflurane anesthesia in mice. The findings identify regulatory T cells (Tregs) as central mediators of Rg1’s neuroprotective effects, suggesting new avenues for mitigating postoperative cognitive complications.

• Structure-Based Screening Identifies NSP15 Inhibitors for SA

  2026-07-17

  This study presents a structure-based virtual screening of natural products against SARS-CoV-2 NSP15, identifying thymopentin and oleuropein as potent, stable inhibitors. The findings highlight NSP15 as a viable antiviral target and suggest new directions for drug repurposing in COVID-19 research.

464 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page